HGERS
REGN icon

Householder Group Estate & Retirement Specialist’s Regeneron Pharmaceuticals REGN Stock Holding History

Householder Group Estate & Retirement Specialist’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$2K Sell
4
-20
-83% -$16.8K ﹤0.01% 488
2024
Q3 		$25K Hold
24
– – 0.01% 635
2024
Q2 		$25K Buy
24
+12
+100% +$11.6K 0.01% 633
2024
Q1 		$11.6K Buy
12
+4
+50% +$3.8K ﹤0.01% 785
2023
Q4 		$7K Hold
8
– – ﹤0.01% 845
2023
Q3 		$6.58K Buy
+8
New +$6.29K ﹤0.01% 875
2023
Q1 		$30K Buy
37
+35
+1,750% +$26.4K 0.01% 548
2022
Q4 		$1K Hold
2
– – ﹤0.01% 348
2022
Q3 		$1K Buy
+2
New +$1.26K ﹤0.01% 1043

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Householder Group Estate & Retirement Specialist's REGN Position: Q4 2024 in Review

Householder Group Estate & Retirement Specialist reduced its Regeneron Pharmaceuticals (REGN) stake by 83% in Q4 2024, selling an estimated $16.8K and leaving 4 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #488.

Householder Group Estate & Retirement Specialist first reported a position in REGN in Q3 2022 and has held it in 9 quarters since. The position peaked at $30K in Q1 2023. 1,318 funds tracked by Wall St. Rank hold REGN as of Q4 2024.

  • Householder Group Estate & Retirement Specialist held 4 shares of Regeneron Pharmaceuticals worth $2K as of Q4 2024.
  • Householder Group Estate & Retirement Specialist sold 20 Regeneron Pharmaceuticals shares in Q4 2024, an estimated $16.8K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Householder Group Estate & Retirement Specialist's portfolio in Q4 2024, its #488 holding.
  • Householder Group Estate & Retirement Specialist first reported a position in Regeneron Pharmaceuticals in Q3 2022 and has held it in 9 quarters since.
  • Householder Group Estate & Retirement Specialist's Regeneron Pharmaceuticals position peaked at $30K in Q1 2023.
  • 1,318 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2024.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q4 2024, filed 15 Jan 2025.